HomeTagsGeorge D. Yancopoulos

George D. Yancopoulos

Healthcare

Dupixent Approved by European Commission as the First and Only Targeted Medicine

PR Newswire - December 15, 2022

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the European Commission (EC) has expanded the marketing authorization for Dupixent (dupilumab) in the European Union to...

Healthcare

Dupixent Phase 3 Trial Shows Positive Results in Children 1 to 11 Years of Age with Eosinophilic Esophagitis

PR Newswire - July 15, 2022

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that a Phase 3 trial assessing the investigational use of Dupixent (dupilumab) in children aged 1 to...